awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38097735-F1E65845-1058-43AB-8635-6711D6DD1657
Q38097735-F1E65845-1058-43AB-8635-6711D6DD1657
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38097735-F1E65845-1058-43AB-8635-6711D6DD1657
Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapy.
P2860
Q38097735-F1E65845-1058-43AB-8635-6711D6DD1657
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38097735-F1E65845-1058-43AB-8635-6711D6DD1657
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e5048c7f7a6ebff82e4593517955e92374273ea
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.